![](/img/cover-not-exists.png)
Cost-Effectiveness of Irbesartan 300 mg Given Early Versus Late in Patients with Hypertension and a History of Type 2 Diabetes and Renal Disease: A Canadian Perspective
Douglas Coyle, Roger Rodby, Steven Soroka, Adeera Levin, Norman Muirhead, Paul René de Cotret, Roland Chen, Andrew PalmerVolume:
29
Year:
2007
Language:
english
Pages:
1524
DOI:
10.1016/j.clinthera.2007.07.029
File:
PDF, 1.08 MB
english, 2007